These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 33247317)

  • 1. Human papilloma virus (HPV) prevalence upon HPV vaccination in Swedish youth: a review based on our findings 2008-2018, and perspectives on cancer prevention.
    Du J; Ährlund-Richter A; Näsman A; Dalianis T
    Arch Gynecol Obstet; 2021 Feb; 303(2):329-335. PubMed ID: 33247317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in Cervical Human Papillomavirus (HPV) Prevalence at a Youth Clinic in Stockholm, Sweden, a Decade After the Introduction of the HPV Vaccine.
    Ährlund-Richter A; Cheng L; Hu YOO; Svensson M; Pennhag AAL; Ursu RG; Haeggblom L; Grün N; Ramqvist T; Engstrand L; Dalianis T; Du J
    Front Cell Infect Microbiol; 2019; 9():59. PubMed ID: 30949454
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of HPV vaccination with Gardasil® in Switzerland.
    Jacot-Guillarmod M; Pasquier J; Greub G; Bongiovanni M; Achtari C; Sahli R
    BMC Infect Dis; 2017 Dec; 17(1):790. PubMed ID: 29273004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ;
    MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent?
    Patel C; Brotherton JM; Pillsbury A; Jayasinghe S; Donovan B; Macartney K; Marshall H
    Euro Surveill; 2018 Oct; 23(41):. PubMed ID: 30326995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Public health impact and cost effectiveness of routine and catch-up vaccination of girls and women with a nine-valent HPV vaccine in Japan: a model-based study.
    Cody P; Tobe K; Abe M; Elbasha EH
    BMC Infect Dis; 2021 Jan; 21(1):11. PubMed ID: 33407188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point-registry-based follow-up of
    Lehtinen M; Lagheden C; Luostarinen T; Eriksson T; Apter D; Harjula K; Kuortti M; Natunen K; Palmroth J; Petäjä T; Pukkala E; Siitari-Mattila M; Struyf F; Nieminen P; Paavonen J; Dubin G; Dillner J
    BMJ Open; 2017 Aug; 7(8):e015867. PubMed ID: 28821519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UK population based study to predict impact of HPV vaccination.
    Hibbitts S; Tristram A; Beer H; McRea J; Rose B; Hauke A; Nuttall D; Dallimore N; Newcombe RG; Fiander A
    J Clin Virol; 2014 Feb; 59(2):109-14. PubMed ID: 24388208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papilloma virus vaccination in Nepal: an initial experience in Nepal.
    Singh Y; Shah A; Singh M; Verma S; Shrestha BM; Vaidya P; Nakarmi RP; Shrestha SB
    Asian Pac J Cancer Prev; 2010; 11(3):615-7. PubMed ID: 21039025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on Effects of the Prophylactic HPV Vaccines on HPV Type Prevalence and Cervical Pathology.
    Hampson IN; Oliver AW
    Viruses; 2024 Aug; 16(8):. PubMed ID: 39205218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of 21 HPV vaccination programs implemented in low and middle-income countries, 2009-2013.
    Ladner J; Besson MH; Rodrigues M; Audureau E; Saba J
    BMC Public Health; 2014 Jun; 14():670. PubMed ID: 24981818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus types in cervical dysplasia among young HPV-vaccinated women: Population-based nested case-control study.
    Kann H; Hortlund M; Eklund C; Dillner J; Faust H
    Int J Cancer; 2020 May; 146(9):2539-2546. PubMed ID: 31868230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decline of HPV infections in Scandinavian cervical screening populations after introduction of HPV vaccination programs.
    Dillner J; Nygård M; Munk C; Hortlund M; Hansen BT; Lagheden C; Liaw KL; Kjaer SK
    Vaccine; 2018 Jun; 36(26):3820-3829. PubMed ID: 29778519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The GARDASIL vaccine can prevent cervical carcinoma caused by human papilloma virus (HPV) (results from our participation and from the study carried out in Greece).
    Ansstasiou-Fotaki P; Deligeoroglou E; Kreatsas G
    Akush Ginekol (Sofiia); 2007; 46(3):17-20. PubMed ID: 18018777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papilloma virus prevalence, genotype distribution, and pattern of infection in Thai women.
    Suthipintawong C; Siriaunkgul S; Tungsinmunkong K; Pientong C; Ekalaksananan T; Karalak A; Kleebkaow P; Vinyuvat S; Triratanachat S; Khunamornpong S; Chongsuwanich T
    Asian Pac J Cancer Prev; 2011; 12(4):853-6. PubMed ID: 21790214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology and prevention of Human Papillomavirus.
    Manini I; Montomoli E
    Ann Ig; 2018; 30(4 Supple 1):28-32. PubMed ID: 30062377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial.
    Muñoz N; Manalastas R; Pitisuttithum P; Tresukosol D; Monsonego J; Ault K; Clavel C; Luna J; Myers E; Hood S; Bautista O; Bryan J; Taddeo FJ; Esser MT; Vuocolo S; Haupt RM; Barr E; Saah A
    Lancet; 2009 Jun; 373(9679):1949-57. PubMed ID: 19493565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine and Non-Vaccine HPV Types Presence in Adolescents with Vertically Acquired HIV Five Years Post Gardasil Quadrivalent Vaccination: The ZIMGARD Cohort.
    Murahwa AT; Mudzviti T; Mandishora RSD; Chatindo T; Chanetsa P; Pascoe M; Shamu T; Basera W; Luethy R; Williamson AL
    Viruses; 2024 Jan; 16(1):. PubMed ID: 38275972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant human papillomavirus (HPV) vaccination and screening for elimination of HPV and cervical cancer.
    Arroyo Mühr LS; Gini A; Yilmaz E; Hassan SS; Lagheden C; Hultin E; Garcia Serrano A; Ure AE; Andersson H; Merino R; Elfström KM; Baussano I; Dillner J
    Nat Commun; 2024 May; 15(1):3679. PubMed ID: 38693149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study.
    Gertig DM; Brotherton JM; Budd AC; Drennan K; Chappell G; Saville AM
    BMC Med; 2013 Oct; 11():227. PubMed ID: 24148310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.